How Browne was paid
$2.5M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Sean E. BrownePresident and Chief Executive Officer | $617,539 | $1,807,132 | $37,065 | $2,461,736 |
| Scott C. NeilsChief Financial Officer | $411,692 | $438,551 | $33,264 | $883,507 |
| Mark A. SchallenbergerChief Operating Officer | $411,692 | $428,469 | $38,800 | $878,961 |
| Kevin D. BrandtFormer Chief Commercial Officer | $315,669 | $454,996 | $460,035 | $1,230,700 |
What changed and why
- $2.5M$2,461,736 was CEO Sean Browne’s 2024 total compensation, compared with $1,712,158 in 2023.
- $1.8M$1,807,132 of Browne’s 2024 compensation came from stock awards.
- No bonuses were earned or paid for 2024 performance.
- $448K$447,846 of Kevin Brandt’s other compensation consisted of severance payments after his position was eliminated.
- The program emphasizes at-risk pay, long-term equity, performance measures, payout caps, and minimum vesting periods.
Other Xtant Medical Holdings proxy statements
- 2026 proxy statement
Sean E. Browne paid $1.4M (-45% on the year).
Filed Jun 23, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.